Neoadjuvant and adjuvant therapy in triple negative breast cancer
Neoadjuvant and adjuvant therapy in triple negative breast cancer
Breast cancer in young women from Asia
Specialising in breast cancer surgery
Expert insight: Managing neutropenia in breast cancer patients
SABCS 2017: The latest in CDK inhibition in breast cancer
Circulating tumour cells may predict late recurrence in HR-positive breast cancer patients
Postmenopausal women who lose weight may have reduced breast cancer risk
Talazoparib vs physicians choice for patients with mBRCA1 breast cancer
CDK 4/6 inhibitors for older women with HR-positive breast cancer
Reducing risk of breast cancer recurrence and death with increased dose density
Breast cancer therapy resistance mediated by FGFR amplification
The significance of CEACAM 5 in metastases of triple negative breast cancer